company background image
GBIO

Generation Bio NasdaqGS:GBIO Stock Report

Last Price

US$6.42

Market Cap

US$381.5m

7D

5.1%

1Y

10.3%

Updated

03 Feb, 2023

Data

Company Financials +

GBIO Stock Overview

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases.

GBIO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Generation Bio Co. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Generation Bio
Historical stock prices
Current Share PriceUS$6.42
52 Week HighUS$9.59
52 Week LowUS$3.55
Beta1.6
1 Month Change26.38%
3 Month Change7.72%
1 Year Change10.31%
3 Year Changen/a
5 Year Changen/a
Change since IPO-74.00%

Recent News & Updates

Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

Nov 19
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

Recent updates

Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

Nov 19
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Aug 05
We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Generation Bio GAAP EPS of -$0.66 misses by $0.04

Aug 04

Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Apr 20
Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Generation Bio: High-Risk, Medium-To-Low-Reward

Dec 30

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Nov 11
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Jul 28
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Mar 08
Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Jan 14
Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Generation Bio's insiders on buying spree, stock +4%

Jan 13

Generation Bio prices equity offering at $24.50

Jan 07

Generation Bio files to offer 7.5M shares

Jan 04

Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Dec 27
Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Generation Bio EPS misses by $0.01

Nov 10

Shareholder Returns

GBIOUS BiotechsUS Market
7D5.1%-0.8%2.9%
1Y10.3%4.5%-8.5%

Return vs Industry: GBIO exceeded the US Biotechs industry which returned 5.3% over the past year.

Return vs Market: GBIO exceeded the US Market which returned -9.1% over the past year.

Price Volatility

Is GBIO's price volatile compared to industry and market?
GBIO volatility
GBIO Average Weekly Movement15.3%
Biotechs Industry Average Movement12.2%
Market Average Movement6.8%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: GBIO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: GBIO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2016150Geoff McDonoughhttps://generationbio.com

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.

Generation Bio Co. Fundamentals Summary

How do Generation Bio's earnings and revenue compare to its market cap?
GBIO fundamental statistics
Market CapUS$381.49m
Earnings (TTM)-US$135.18m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GBIO income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$135.18m
Earnings-US$135.18m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.27
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did GBIO perform over the long term?

See historical performance and comparison